Logo

US aims to quicken approvals for cheaper versions of complex drugs

US aims to quicken approvals for cheaper versions of complex drugs

The US Food and Drug Administration said Wednesday it would ease the approvals process for developing replicas of biologic drugs used to treat conditions including autoimmune diseases, cancer and diabetes.

👉 Full Story